Nifty Pharma index hit a 52-week high of 20,575.35, but ended with a 0.63% loss due to profit booking. The index has risen nearly 48% in the last year, outperforming the benchmark Nifty 50. Most pharma stocks have gained significantly, with 12 out of 20 components rising at least 50% or more over the last year. The pharma sector is expected to reach $65 billion by 2024 and $130 billion by 2030.
Open FlipExxon Mobil expects changes in oil prices to boost its second-quarter upstream earnings by $300 million to $700 million, compared to the first quarter. This increase follows the company's $5.7 billion in upstream earnings for the first quarter ended March 31, highlighting a potential significant profit surge for the largest US oil producer.
Open FlipTrump Media & Technology Group Corp (NASDAQ:DJT) shares traded 0.93% higher to $29.44 premarket on Monday after Donald Trump distanced himself from a controversial policy blueprint for his potential second presidential term. Trump is the majority shareholder of DJT, which recently acquired Perception Group's CDN technology and secured a $2.5 billion equity purchase agreement for future expansion.
Open Flip